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The impact of neurodegeneration can be understood in terms of its effect on the structure and function of brain networks. For example, there are structural anatomical fingerprints for Alzheimer’s Disease (AD) and frontotemporal dementia (FTD), and disease-specific changes in their functional connectivity with ‘epicentres’ of disease(Seeley et al., 2009; Zhou et al., 2010; Crossley et al., 2014). Moreover, the distribution of abnormal connectivity mirrors the anatomical and functional networks in health, suggesting selective vulnerability of brain networks to neuropathology (Pievani et al., 2011). 

The evidence for network-specific changes in major human dementia syndromes comes largely from functional Magnetic Resonance Imaging (MRI). However, MRI indirectly examines the physiological consequences of neuropathology. For example, in Alzheimer’s disease misfolding and aggregation of beta-amyloid (Aβ) and microtubule-associated protein Tau (MAPT), occur in a cascade that ultimately impacts on synaptic function and cell survival(Spires-Jones and Hyman, 2014). Functional MRI can detect the late consequences of this cascade on connectivity (Bullmore and Sporns, 2009; Fornito et al., 2015a), but it is limited by slow and indirect neurovascular signaling (Hillman, 2014; Tsvetanov et al., 2015). In contrast, magnetoencephalography (MEG) and electroencephalography (EEG) offer a temporal resolution that can resolve changes in neural dynamics that are indistinguishable by fMRI, and that are independent of effects of age or medication on the neurovascular response(de Haan et al., 2012; Hughes et al., 2013; Tsvetanov et al., 2015). 

Clinical research applications of EEG have reported features that distinguish AD from controls (Triggiani et al.,2017); predict the conversion from mild cognitive impairment to dementia (Poil et al, 2013); and provide pre-symptomatic markers of autosomal dominant disease (Quiroz et al.,2017). In contrast, clinical EEGs of frontotemporal dementia are often regarded as normal, although abnormalities at the group level have been shown (Chan et al., 2004). Beyond clinical applications, the spectral and spatial resolution of MEG and EEG enables one to test key hypotheses of human neurodegeneration; identifying the re-organization of networks in dementia; and providing potential biomarkers for diagnosis, prognosis or drug response (Maestu et al., 2015; Hughes and Rowe, 2013; Hughes et al., 2013, 2015).  

Here, we exploit the spatiotemporal precision of MEG to build on preclinical models of dementia, and determine the specificity of pathophysiological signatures of Alzheimer’s disease pathology versus frontotemporal lobar degeneration. For example, transgenic rodent models of AD have indicated specific alterations in fast network dynamics, resulting in loss of gamma power (30+ Hz) in cortical and hippocampal local networks (Kurudenkandy et al., 2014). Analogous changes in network dynamics can be identified in humans, noting that the distribution of disease can vary between early medial-temporal lobe changes in typical AD (tAD), versus an occipito-parietal focus in the posterior cortical atrophy (PCA) variant(Selkoe, 2002; Crutch et al., 2012; Pena-Ortega et al., 2012). The behavioural variant of FTD (bvFTD) on the other hand, is often associated with tauopathy in the absence of beta-amyloid, for which electrophysiological recordings in rodent tauopathy models indicate power reductions in the lower frequency bands; alpha (8-13 Hz) and beta (14-30 Hz)(Koss et al., 2016). Frontotemporal lobar degeneration also encompasses the non-fluent agrammatic variant of primary progressive aphasia (navPPA) and progressive supranuclear palsy (PSP, Richardson’s syndrome), which are both most commonly caused by primary tauopathy but which differ in the severity and location of atrophy(Ghosh et al., 2012; Mandelli et al 2016) .

Our overarching hypothesis was that different neuropathologies have characteristic physiological signatures, which reflect both the anatomical distribution of pathology and their impact on the oscillatory dynamics of cortical circuits. We predicted that tAD and PCA would differ in the localization of their functional effects, but that the changes in oscillatory dynamics within affected regions would be similar. In contrast, we predicted that three sub-types of frontotemporal lobar degeneration would have different spectral and spatial properties compared to AD, whilst their spectral properties may be similar to each other albeit in different spatial distributions and with distinct clinical phenotypes. The significance of MEG-based differentiation of these five syndromes is not primarily for utility as a diagnostic biomarker, in competition with other biomarkers. Rather, it lies in establishing their pathophysiological signatures in humans in vivo, extending the network paradigm of neurodegeneration to the spectral domain, and validating translational models of disease.  

Our principle measure of network function was local efficiency, which indicates a network’s local information transfer and resilience(Bullmore and Sporns, 2009; Stam, 2014). This measure is therefore ideally suited to examine the effect of degenerative syndromes associated with regional variations in pathology. Note that locality here refers to topological locality, and not Euclidean locality or physical proximity. The reorganisation of brain networks can also be measured in terms of global properties (e.g. Small worldness), or the changes in the properties of hub regions that are critical for effective long-range integration (Crossley et al., 2014). However, we focus on local efficiency although neurodegeneration is diffuse, it is not uniformly distributed: both FTD and Alzheimer’s disease variants like PCA manifest clear regional specificity, in keeping with their nomenclature. Moreover, a potential advantage of the neurophysiological approach is greater sensitivity to network reorganization before extensive cell death leads to atrophy (Knight and Verkhratsky, 2010; Palop and Mucke, 2010; Hughes et al., 2013). 

Materials and Methods 

Participants
Patients were enrolled from tertiary clinics at Cambridge University Hospitals NHS Trust. Patients with Alzheimer’s disease included thirteen with tAD (McKhann et al., 2011) and eleven with PCA(Crutch et al., 2012). Patients with clinical syndromes associated with frontotemporal lobar degeneration comprised thirteen patients with bvFTD(Rascovsky et al., 2011), all with abnormal structural MRI and evidence of progression; fifteen with PSP (Litvan et al., 1996) and eleven with navPPA (Gorno-Tempini et al., 2011). The PSP cases meet the definition for probable or definite PSP-Richardson’s syndrome under the revised diagnostic criteria (Hoeglinger et al, 2017). Fifteen healthy adult participants were recruited (11 males; age 59 -85 years) with no history of neurological or psychiatric illness. The study was approved by the local Research Ethics Committee and written informed consent was obtained in accordance with the standards of the Declaration of Helsinki. Patients undertook the Mini Mental State Examination (MMSE) and the revised Addenbrooke’s cognitive examination (ACE-R). The clinical and cognitive features of the patients are summarized in Table 1.
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Experimental Design and data acquisition 
  
Figure 1 illustrates the flow of the processes involved in the data acquisition, preprocessing and analysis. All participants rested with their eyes closed while MEG was continuously recorded at 1 kHz sampling rate from 204 planar gradiometers using a Vectorview system (Elekta Neuromag) within a magnetically shielded room. The first 30-40s of data were discarded to allow the participant to settle, resulting in 4 minutes of data per participant. Horizontal and vertical electro-oculograms (EOG) were recorded and the participants’ head position was tracked with 5 head position indicator coils, localised in three dimensions together with approximately 100 head points for anatomical registration using a 3-D digitizer (Fastrak Polhemus, Inc., Colchester, VA). The removal of environmental artefacts and head position alignment used the temporal extension of Signal Space Separation (tSSS) with Elekta-Neuromag MaxFilter version 2.2. Oculomotor artefacts were removed by Independent Component Analysis (ICA), followed by projection out of the data of those ICs that correlated highly with either of the two EOG signals (typically 1-3 ICs per participant) (Gonzalez-Moreno et al., 2014).
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To examine the effect of neurodegeneration on network connectivity, we applied multivariate autoregressive modelling (MVAR) to the root mean square (RMS) of the two planar gradiometers at each of the 102 locations around the head. One advantage of MVAR is that it ignores zero-lag correlations, which include those arising from volume conduction of a single brain source to multiple sensors. This reduces the need for source reconstruction of the MEG data; an inverse problem that cannot be solved without additional assumptions. 

To reduce dimensionality and zero-lag co-linearity, and increase Gaussianity, we performed principal components analysis on the RMS data and retained the first 60 principal components (which accounted for over 99% of the total variance). The MVAR was fit to the lagged covariance matrices using the Vieira-Morf method. For MVAR modelling, an important step is to specify the model order, p (i.e. the number of past samples needed to predict the current sample). To find the optimal balance between model fit and complexity, we used the Bayesian Information Criterion (BIC), which resulted in an optimal model order of p=8 for all groups. To test whether the data were stationary we used the Stability Index (SI): data are stationary if and only if 0. This confirmed that the MVAR modelling did not significantly deviate from stationarity in any participant.

After projecting the fitted MVAR parameters back into sensor-space, we estimated Partial Directed Coherence (Baccalá and Sameshima, 2001; Schelter et al., 2006; Williams et al., 2014) between all 102 sensor locations. Partial directed coherence is a frequency-specific, measure of connectivity that preserves the directionality of interactions, and has been shown to provide good reliability for group studies (Colclough et al., 2016). Partial directed coherence was estimated every 0.1Hz from 1-80Hz to create a 102x102 matrix for each of 800 frequencies, using the significance for which the p-values threshold was then binarized by taking the top 15% of significant connections for each frequency bin (i.e, a threshold of 85%, based on simulations below). The binary connectivity matrices were then used to estimate local efficiency for each node (location) and frequency. 

Simulations 





To correct for multiple tests across sensors and frequencies in the MEG analysis, we projected the 102 sensor locations onto a 2D plane, and interpolated their local efficiency values onto a 64x64 grid using SPM8 (http://www.fil.ion.ucl.ac.uk/spm), resulting in a 3D scalp-by-frequency image (64x64x800), which was smoothed with a Gaussian kernel (8mm x 8mm x 8Hz). Pairwise differences between groups were then assessed with Statistical non-Parametric Mapping (SnPM, http://warwick.ac.uk/snpm), which used 5000 permutations to generate pseudo-T distributions that are robust to small sample sizes and do not assume Gaussian error. A cluster based extension was implemented to detect statistically significant clusters on t-maps (Hayasaka and Nichols, 2004). The cluster value was set to conform to the 95th percentile of the data driven distribution, and significant clusters were set to p<0.05. For interpretation, the frequencies were subdivided into delta (<4 Hz), theta (4–7 Hz), alpha (8–13 Hz), beta (14–30 Hz), gamma (30–50 Hz), and high-gamma activity (>50 Hz) bands.

Classification of participants
In the final analyses, we used multivariate pattern classification to identify the distinctions between two or more groups, enabling subject-specific group assignment based on the spatio-spectral characteristics of the networks’ local efficiency. Pattern recognition was implemented in Matlab (R2012b; Mathworks, Natick, MA) using the Mania toolbox (https://bitbucket.org/grotegerd/mania) which incorporates the LIBSVM software library for the kernel based support vector classification used (https://www.csie.ntu.edu.tw/~cjlin/libsvm/). Support vector machines automatically calculate decision boundaries (hyperplanes) in a high-dimensional feature space based on training data with known outcome; new data are then placed into this space and outcome (prediction accuracy) determined according to its position relative to the hyperplane. 
We used linear kernels for the SVM classification with parameters bounded between (0,1).

Before classification, we extracted low dimensional data features to improve performance, by using (i) a Z statistic which was calculated over every voxel and (ii) principal components analysis of the 3-D frequency-x-scalp image of local efficiency. We applied leave-one-out cross-validation, iteratively dividing the data into separate training and testing sets with balanced groups and re-ran this iteration ten-fold to ensure stability. Finally, the classification performance from the support vector machine is described in terms of the Area Under the Curve (AUC) of a Receiver Operating Characteristic (ROC).   

Results 
A summary of demographic and clinical measures for the patient groups is reported in Table 1. Across the five clinical groups and controls, there was a group-wise difference in age p<0.05. However, Tukey HSD tests and Holm correction for multiple comparisons, confirmed that only the PCA group were distinct in age, being younger (Table 1). All groups differed from controls in MMSE and ACE-r scores, as expected (Table 1). 

Figure 2 shows sections through the 3D scalp frequency images of statistical differences between groups in local efficiency. Compared to controls (HC), tAD reduced local efficiency over temporal cortex (Figure 2A). This effect was not equivalent across all frequencies, but was observed in the gamma range. The PCA variant of Alzheimer’s disease also caused a similar reduction in gamma band local efficiency, but in a different distribution that lay over more posterior regions (Figure 2B). 
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A physiologically distinct signature was observed for the frontotemporal lobar degeneration syndromes. For both PSP and bvFTD (Figures 2C and 2D), local efficiency was reduced in lower frequencies, extending from delta through alpha to low gamma. These changes were evident over frontal cortex. While navPPA showed a similar reduction at low frequencies particularly in the delta/theta range, the distribution of the changes was different to that seen in bvFTD and PSP, focused on centro-parietal regions (Figure 2E). 
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Figure 3 shows ROCs for each binary classification of patient groups, based on the spatial and spectral distributions of local efficiency. Across all the comparisons of AD variants versus FTLD variants, classification performance (AUC) ranged from 0.78 to 1. AUC for distinguishing between the two AD variants tAD and PCA was 0.74, while that for distinguishing the three FTD variants ranged from 0.62 (bvFTD versus PSP) to 1 (bvFTD versus navPPA). 

Supplementary figure 1 shows ROCs for classification of each patient group versus controls, based on the spatial and spectral distributions of local efficiency. The difference was highest for bvFTD group followed by tAD, with classification performance (AUC) at 0.96 and 0.85 respectively, and above-chance lower classification rates for PSP (0.76), navPPA (0.63) and PCA (0.60). 






We have identified distinctive neurophysiological signatures associated with five neurodegenerative disorders resulting from Alzheimer’s disease and frontotemporal lobar degeneration. The signatures are characterized in terms of both the spatial and frequency profiles of local efficiency in brain networks (local in topological terms). The anatomical distribution of changes in local efficiency across the five syndromes was predicted by the functional anatomy of their principal cognitive deficits. However, the disorders were also distinguished by their spectral pattern of connectivity, according to the likely underlying neuropathology.
In recent years the majority of MEG based dementia related studies have focused on potential diagnostic or prognostic biomarker utility (Stam 2014). We confirm that the spectral dynamics and topography of local efficiency enabled classification of patients using a simple machine learning approach, with highest accuracy for classification between disorders. However, in the following discussion, we evaluate our results in relation to Alzheimer pathology, frontotemporal lobar degeneration and the insights into pathogenic mechanisms from a network-based approach. 
We focus on local network efficiency as one of the strongest indicators of underlying pathology in AD and FTD (Stam 2014; Medaglia et al.2017). Other graph network metrics have been reported to be sensitive to the effects of neurodegeneration, including measures of global integration or organisation. For example, previous MEG studies have shown the importance network modularity and of hub connections in AD (de Hann et al. 2011; Stam. 2014) while a multi-layer frequency-band approach reveals the disruption of hubs in AD patients (Yu et al., 2017). Recent simulations demonstrate the link between directed functional connectivity and hubs (Moon et al., 2015; Meier et al., 2017). This challenges the simple dichotomy between ‘local’ or ‘global’ integration, as hubs are themselves unevenly distributed yet influence global connectivity (Stam 2014). Conversely, the changes in local efficiency we observed in AD are very widespread across the brain. Distributed changes in local efficiency metrics may also contribute to part of the frequently reported change in global efficiency and hub connectivity in multiple neurological disorders (Crossley et al, 2014). For example, closeness centrality is a characteristic of hubs that is directly proportional to their local efficiency (Sporns et al., 2007). Our results highlight the distributed disruption of characteristic spectral signatures of physiological coupling in neurodegenerative disorders. Additionally, the local efficiency metric signifies tolerance in a network to a node’s removal i.e. a subgraph or a local network’s vulnerability is related to the reduction of the local efficiency of its contributing regions or nodes (Latora and Marchiori, 2001; Medaglia et al,.2017). This is of special interest in view of the impact of neuropathological burden as measured by PET on connectivity (Cope et a.l, 2018).
While network degeneration can be characterized at the microscopic level, or at the level of global brain function, we measured network dynamics at an intermediate scale, to reflect the regional variations in pathology in each of the five disorders. In the context of brain network dynamics, we confirmed the hypothesis that disorders that share a common underlying pathology have a similar spectral signature of altered connectivity, regardless of phenotype. This neurophysiological finding is distinct from the previously established relationships between the structural connectome, pathology and syndrome (Zhou et al., 2012; Raj et al., 2012).

Alzheimer’s disease 
Previous work in AD models and patients has demonstrated reductions in relative spectral power in high beta-gamma bands (Poza et al., 2007), despite methodological differences between electrophysiological studies (Dauwels et al., 2010). For example, in a network analysis using EEG, Peterson et al. (2001) found small-worldness of networks in the gamma band correlated with cognitive performance in prodromal Alzheimer’s disease. Preclinical models have investigated the aetiology of these changes, including the analogous loss of gamma power and theta-gamma coupling in cortical and hippocampal local networks in transgenic mouse models (Kurudenkandy et al., 2014). For example, Aβ suppresses power in the beta-gamma frequency range from entorhinal cortex and induces desynchronization of pyramidal cells with a shift of the excitatory-inhibitory equilibrium (Pena-Ortega et al., 2012; Kurudenkandy et al., 2014). Neurodegenerative disease processes not only reduce synaptic density on pyramidal cells, and their local interactions with inhibitory interneurons, but also reduce neurotransmitters such as GABA (Selkoe, 2002; Huey et al., 2006). Given the key role of GABA in driving the gamma response in humans (Muthukumaraswamy, 2014), our observations may result from neurochemical as well as structural changes in cortical networks, in tAD and PCA.   
While PCA and tAD were both associated with similar changes in spectral density, they had different scalp distributions of abnormality that reflected the known distribution of underlying pathology, with a parietal peak for PCA and predominantly temporal distribution for tAD, in keeping with our principal hypothesis. The regional distribution of abnormal MEG-based connectivity cannot be equated with MRI or PET findings. For example, planar gradiometers will be relatively insensitive to bilateral precuneus pathology in AD by virtue of depth and orientation. The abnormal local efficiency in tAD also appears to be more extensive on the left, as has been noted before (Long et al. 2013), but such laterality effects should be viewed with caution, without inferring unilateral pathology: indeed by the stage of clinically-diagnosed, symptomatic Alzheimer disease, both amyloid and tau pathologies are likely to be bilateral and widespread (Jagust, 2016; Ossenkoppele et al., 2016; Passamonti et al, 2017). If spatio-temporal connectivity signatures are to provide a framework to understand multiple neurodegenerative disorders, complementary signatures are predicted for other pathologies and syndromes, to which we turn in the next section. 

Frontotemporal lobar degeneration syndromes. 
We studied three syndromes associated with frontotemporal lobar degeneration: behavioral variant frontotemporal dementia (bvFTD); non-fluent agrammatic variant primary progressive aphasia (navPPA); and classical progressive supranuclear palsy (PSP-Richardson’s syndrome). The clinicopathological correlation of PSP is very high, with 90-95% of cases due to a glioneuronal 4-repeat tauopathy (Litvan et al., 1996; Frank et al., 2007). Eleven of our PSP patients have since died, of whom seven donated their brain to the Cambridge Brain Bank: all seven had pathological confirmation of PSP. MRI studies reveal PSP-related atrophy of medial frontal cortex (Ghosh et al., 2012) and the loss of frontocentral local efficiency in Figure 2 accords with this structural change. The MEG analysis revealed a selective loss in low frequency connectivity up to the high beta range. 

navPPA has weaker clinicopathological correlations, but it is also associated with 4-repeat tauopathy in the majority of cases, while a minority have TDP-43 pathology (Gorno-Tempini et al., 2011). Atrophy is typically not severe. bvFTD is the most neuropathologically diverse form, and may arise from 3-repeat or 4-repeat tauopathy or TDP-43 pathology (Boeve, 2007). The clinical syndrome is united by specific and severe  layer II/III atrophy of temporal poles, plus moderate to severe atrophy of orbital and ventral frontal cortex (Hughes et al., 2015). Like PSP, both navPPA and bvFTD reduced the local efficiency in the delta and beta bands, but the spatial and temporal characteristics of these changes were specific, with near complete separation of bvFTD and navPPA from the other syndromes (Figure 3) reinforcing the multimodal separation of Alzheimer’s disease from navPPA (Hu et al., 2010). 

During our classification procedure, bvFTD was not well separated from PSP, which is interesting in view of the phenotypic overlap, given that PSP can present cognitive and behavioral change and many patients with bvFTD later develop a supranuclear gaze palsy and/or parkinsonism (Burrell et al., 2014; Coyle-Gilchrist et al., 2016; Hoeglinger et al, 2017). Here, both PSP and bvFTD were associated with loss of low frequency connectivity, in keeping with animal models of tau-mediated frontotemporal lobar degeneration. For example, PLB2-tau mice show absolute power reductions in alpha/band (9–14 Hz) in frontal and parietal locations (Koss et al., 2016). 

Network based biomarkers of neurodegeneration 
The connectivity approach is ideally suited to the distributed nature of neuropathology and the impact of disease on the axon and synapse. Covariance-based resting-state networks identified from MEG/EEG are reliable and sensitive to a wide range of neurodegenerative diseases (Stam, 2010; Hughes and Rowe, 2013). However, our use of directed graphs, or effective connectivity embodying directionality, extends this work and accommodates potential asymmetries in large-scale brain networks. MEG and EEG allow one to identify reciprocal connections across a range of frequencies: this makes them well suited to characterize the impact of dementia on connectivity in vivo, while maintaining compatibility with invasive electrophysiological studies of networks (Muthukumaraswamy, 2014; Phillips et al., 2015). 

We used partial directed coherence to quantify connectivity, a method related to Granger causality. Partial directed coherence estimates directional connectivity between regions based on their functional timeseries. An advantage of this method for MEG/EEG is that it is less sensitive to the field spread that otherwise inflates instantaneous correlation metrics (Baccalá and Sameshima, 2001; van Dellen et al., 2013; Colclough et al., 2016). When combined with the focal field-of-view of planar gradiometers, simulation studies confirm that multivariate autoregressive modelling minimises field spread while remaining veridical to source-space interactions (Pereira et al., 2016). Indeed, our own simulations confirmed that this approach can recover average local efficiency of source-level networks, provided SNR is sufficiently high (Supplementary Figure 2). The use of sensory-level PDC avoids the extra assumptions that are needed to optimize the electromagnetic “inverse problem” (Baillet et al., 2001). However, we acknowledge that planar gradiometers are only sensitive to relative superficial cortical activity, and we may have missed the effects of disease in deeper brain structures (such information might be present in magnetometer data, but would require source reconstruction to infer network properties).

Partial directed coherence informed the graph theoretical measures of network function. Graph theory reveals fundamental properties of brain network organization in health and has shown homologous vulnerabilities across many neurological and psychiatric disorders (Stam, 2014). The network-level description supports comparisons across modalities, scales and disorders (Fornito et al., 2015b). There are many measures of global network properties, such as small-worldness or global efficiency, but we focus here on local efficiency for two reasons. First, many neurodegenerative diseases are characterized by regional rather than global pathology. Second, it describes the local information transfer and resilience of a network. Third, previous
Previous studies have suggested that local efficiency, and its counterpart of local clustering, are impaired by neurodegeneration and can be sensitive to pathology even in the absence of focal atrophy (Stam, 2014). Recent neuroimaging-based network models have identified local network efficiency as one of the strongest indicators of underlying pathology in AD and FTD (Medaglia et al.2017). These properties make it ideal to elucidate the mechanisms of lobar neurodegenerative disorders with differing atrophic burdens (Seeley et al., 2009; de Haan et al., 2012; van Dellen et al., 2013; Stam, 2014; Hughes et al., 2015). It should be noted that our measures of local efficiency are derived from directed, but binarized, connections. The direction of connections is important because it affects the local efficiency measure (vanWijk et al., 2010). It is possible that weighted (rather than binarized) connections would further inform graph metrics, but one cannot compare PDC values across different sending sensors, so binarization is required (which we implemented here by thresholding the highest 85% of PDC values).  

There are limitations to our study. Severe atrophy is characteristic of tAD, PCA and bvFTD (Rabinovici et al., 2007; Crutch et al., 2012;Whitwell and Josephs, 2012), and this might influence the sensors’ sensitivity to cortical sources and their connectivity. However, focal cortical atrophy in PSP and navPPA is usually mild or absent (Cope et al., 2018), even though it can be evident in group studies (Ghosh et al., 2012; Mandelli et al 2016). Moreover, a simple loss of sensitivity due to atrophy would not be a sufficient explanation of our results. The selective impairment of certain frequency bands suggests that our results are not merely a result of volume loss and increased distance from source to sensor: this is likely to affect all frequencies and be less reduced in PSP and navPPA (Bastos and Schoffelen, 2016). The frequency-specificity of group differences also argue against a simple model of cortical oscillatory dynamics in which higher frequencies are nested in low frequency oscillations (Lakatos et al., 2008; Lisman and Jensen, 2013). This may be due to the selective impact of AD and frontotemporal lobar degeneration on superficial and deep cortical layers, or to the selective breakdown of the neurochemical modulation of brain states (Uhlhaas and Singer, 2006).

Our analyses focus on sensor space using planar gradiometers, rather than magnetometers or attempting to reconstruct source space activity. Several methods exist reconstruct source space activity. However, the accuracy of these methods in conjunction with graphical network analysis is not yet established, and the good approximation of planar gradiometer topography to underlying cortical sources provides sufficient resolution to test our current hypotheses. Simulation studies confirm that multivariate auto-regression modeling is more robust in sensor space (Michalareas et al. 2013), while the use of lagged interaction measures from planar gradiometer data are less sensitive to field-spread (Pereira et al. 2017). Our own simulations provided further evidence that the analysis of sensor space graph metrics accords with source space generators of the data. 

Another limitation is that our groups are defined by clinical diagnostic criteria, without pathological or genetic confirmation except for PSP. However, all our patient participants had well established disease, not peri-symptomatic or mild cognitive impairment. With this degree of severity, the clinicopathological correlations are high for PSP, tAD, and PCA. Pathology would be of interest in bvFTD to differentiate those with Tau- versus TDP43-pathology, although consensus clinical diagnostic criteria are reliable in separating bvFTD from AD. There are potentially significant effects of age on MEG-derived power spectra (Tsvetanov et al, 2015). These might confound the PCA results, being younger than other groups, although such age-effects would not explain the spectral similarity between PCA and tAD, or the differences between tAD and other groups. 




















Baccalá LA, Sameshima K. Partial directed coherence: a new concept in neural structure determination. Biol. Cybern. 2001; 84: 463–474.Baillet S, Riera JJ, Marin G, Mangin JF, Aubert J, Garnero L. Evaluation of inverse methods and head models for EEG source localization using a human skull phantom. Phys. Med. Biol. 2001; 46: 77–96.Bastos AM, Schoffelen J-M. A Tutorial Review of Functional Connectivity Analysis Methods and Their Interpretational Pitfalls. Front. Syst. Neurosci. 2016: 175.Boeve BF. Links Between Frontotemporal Lobar Degeneration, Corticobasal Degeneration, Progressive Supranuclear Palsy, and Amyotrophic Lateral Sclerosis: Alzheimer Dis. Assoc. Disord. 2007; 21: S31–S38.Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009; 10: 186–198.Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: A review. Mov. Disord. 2014; 29: 684–693.Chan, D., Walters, R. J., Sampson, E. L., Schott, J. M., Smith, S. J., & Rossor, M. N.  EEG abnormalities in frontotemporal lobar degeneration. Neurology. 2004; 62: 9 1628-1630Colclough GL, Woolrich MW, Tewarie PK, Brookes MJ, Quinn AJ, Smith SM. How reliable are MEG resting-state connectivity metrics? NeuroImage 2016; 138: 284–293.Coyle-Gilchrist ITS, Dick KM, Patterson K, Rodríquez PV, Wehmann E, Wilcox A, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 2016; 86: 1736–1743.Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K et al. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.Brain. 2018 Feb 1;141(2):550-567Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 2014; 137: 2382–2395.Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012; 11: 170–178.Dauwels J, Vialatte F, Musha T, Cichocki A. A comparative study of synchrony measures for the early diagnosis of Alzheimer’s disease based on EEG. NeuroImage 2010; 49: 668–693.van Dellen E, Hillebrand A, Douw L, Heimans JJ, Reijneveld JC, Stam CJ. Local polymorphic delta activity in cortical lesions causes global decreases in functional connectivity. NeuroImage 2013; 83: 524–532.Fornito A, Zalesky A, Breakspear M. The connectomics of brain disorders. Nat. Rev. Neurosci. 2015; 16: 159–172.Frank S, Clavaguera F, Tolnay M. Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol. (Berl.) 2007; 115: 39–53.Ghosh BCP, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 2012; 135: 2089–2102.Gonzalez-Moreno A, Aurtenetxe S, Lopez-Garcia M-E, del Pozo F, Maestu F, Nevado A. Signal-to-noise ratio of the MEG signal after preprocessing. J. Neurosci. Methods 2014; 222: 56–61.Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006–1014.de Haan W, Mott K, van Straaten ECW, Scheltens P, Stam CJ. Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer’s Disease. PLoS Comput Biol 2012; 8: e1002582.de Haan W, van der Flier WM, Koene T, Smits LL, Scheltens P, Stam CJ. Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease. Neuroimage. 2012 Feb 15;59(4):3085-93de Haan W, Pijnenburg YAL, Strijers RLM, van der Made Y, van der Flier WM, Scheltens P, et al. Functional neural network analysis in frontotemporal dementia and Alzheimer’s disease using EEG and graph theory. BMC Neurosci. 2009; 10: 101.Hayasaka S, Nichols TE. Combining voxel intensity and cluster extent with permutation test framework. NeuroImage 2004; 23: 54–63.Hillman EMC. Coupling Mechanism and Significance of the BOLD Signal: A Status Report. Annu. Rev. Neurosci. 2014; 37: 161–181.Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al.Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria  Mov. Disord. 2017; 32: 853–864.Hu WT, McMillan C, Libon D, Leight S, Forman M, Lee VM-Y, et al. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 2010; 75: 595–602.Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 2006; 66: 17–22.Hughes LE, Ghosh BCP, Rowe JB. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. NeuroImage Clin. 2013; 2: 459–468.Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain 2015; 138: 1961–1975.Hughes LE, Rowe JB. The Impact of Neurodegeneration on Network Connectivity: A Study of Change Detection in Frontotemporal Dementia. J. Cogn. Neurosci. 2013; 25: 802–813.Jagust, W. Is amyloid- β harmful to the brain? Insights from human imaging studies. Brain. 2016; 139: 23–30Knight RA, Verkhratsky A. Neurodegenerative diseases: failures in brain connectivity? Cell Death Differ. 2010; 17: 1069–1070.Koss DJ, Robinson L, Drever BD, Plucińska K, Stoppelkamp S, Veselcic P, et al. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology. Neurobiol. Dis. 2016; 91: 105–123.Kurudenkandy FR, Zilberter M, Biverstål H, Presto J, Honcharenko D, Strömberg R, et al. Amyloid-β-Induced Action Potential Desynchronization and Degradation of Hippocampal Gamma Oscillations Is Prevented by Interference with Peptide Conformation Change and Aggregation. J. Neurosci. 2014; 34: 11416–11425.Lakatos P, Karmos G, Mehta AD, Ulbert I, Schroeder CE. Entrainment of Neuronal Oscillations as a Mechanism of Attentional Selection. Science 2008; 320: 110–113.Latora V, Marchiori M. Efficient behavior of small-world networks. Phys Rev Lett 2001;87:198701Lindau, M., Jelic, V., Johansson, S.-E., Andersen, C., Wahlund, L.-O., & Almkvist, O.  Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders. 2003;15: 106–114Lisman JE, Jensen O. The Theta-Gamma Neural Code. Neuron 2013; 77: 1002–1016.Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.Long X, Zhang L, Liao W, Jiang C, Qiu B. Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer’s disease from healthy aging: statistical parametric mapping with high resolution MRI. Hum Brain Mapp 2013;34:3400–10.Maestu, F., Pena, J. M., Garces, P., Gonzalez, S., Bajo, R., Bagic, A.,  Magnetoencephalography International Consortium of Alzheimer’s, D. A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity. Neuroimage Clin. 2015; 9: 103-109Medaglia, J. D., Huang, W., Segarra, S., Olm, C., Gee, J., Grossman, M., Bassett, D. S. (2017). Brain network efficiency is influenced by the pathologic source of corticobasal syndrome. Neurology, 2017; 89: 1373–1381 Mandelli ML, Vilaplana E, Brown JA, Hubbard HI, Binney RJ, Attygalle S, et al. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia. Brain 2016; 139: 2778–2791.Meier J, Zhou X, Hillebrand A, Tewarie P, Stam CJ, Van Mieghem P. The epidemic spreading model and the direction of information flow in brain networks. Neuroimage. 2017 May 15;152:639-646.Moon JY, Lee U, Blain-Moraes S, Mashour GA. General relationship of global topology, local dynamics, and directionality in large-scale brain networks.  PLoS Comput Biol. 2015 Apr 14;11(4):e1004225.McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. J. Alzheimers Assoc. 2011; 7: 263–269.Muthukumaraswamy SD. The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG). J. Psychopharmacol. (Oxf.) 2014: 269881114536790.Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., Rabinovici, G. D. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain. 2016; 139:1551–1567Passamonti, L., Vazquez Rodriguez, P., Hong, Y. T., Allinson, K. S., Williamson, D., Borchert, R. J., … Rowe, J. B. 18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy. Brain. 2017; 140: 781–791Palop JJ, Mucke L. Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat. Neurosci. 2010; 13: 812–818.Pena-Ortega F, Solis-Cisneros A, Ordaz B, Balleza-Tapia H, Javier Lopez-Guerrero J. Amyloid Beta 1-42 Inhibits Entorhinal Cortex Activity in the Beta-Gamma Range: Role of GSK-3. Curr. Alzheimer Res. 2012; 9: 857–863.Pereira, S., Hindriks, R., Miihlberg, S., Maris, E., van Ede, F., Griffa, A., Hagmann, P., Deco, G.   Effect of field spread on resting-state MEG functional network analysis: a computational modeling study. Brain Connectivity 2017; 7: 541-557 Petersen, R. C., Doody, R., Kurz, a, Mohs, R. C., Morris, J. C., Rabins, P. V, Winblad, B. Current concepts in mild cognitive impairment. Archives of Neurology, 2001; 58: 1985–1992Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. Functional network disruption in the degenerative dementias. The Lancet Neurology. 2011:10: 829-843Phillips HN, Blenkmann A, Hughes LE, Bekinschtein TA, Rowe JB. Hierarchical Organization of Frontotemporal Networks for the Prediction of Stimuli across Multiple Dimensions. J. Neurosci. 2015; 35: 9255–9264.Poil, S. S., de Haan, W., van der Flier, W. M., Mansvelder, H. D., Scheltens, P., & Linkenkaer-Hansen, K. Integrative EEG biomarkers predict progression to Alzheimer’s disease at the MCI stage. Frontiers in Aging Neuroscience. 2013; 5:58Poza J, Hornero R, Abasolo D, Fernandez A, Escudero J. Analysis of Spontaneous MEG Activity in Patients with Alzheimer’s Disease using Spectral Entropies. In: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2007. p. 6179–6182.Quiroz, Y. T., Ally, B. A., Celone, K., McKeever, J., Ruiz-Rizzo, A. L., Lopera, F., … Budson, A. E. Event-Related potential markers of brain changes in preclinical familial Alzheimer disease. Neurology. 2011 77:469-75Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, et al. Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer’s Disease and Frontotemporal Lobar Degeneration. Am. J. Alzheimers Dis. Other Demen. 2007; 22: 474–488.Raj, A., Kuceyeski, A., & Weiner, M.. A Network Diffusion Model of Disease Progression in Dementia. Neuron. 2012; 73: 1204-1215Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456–2477.Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62: 42–52.Selkoe DJ. Alzheimer’s Disease Is a Synaptic Failure. Science 2002; 298: 789–791.Spires-Jones TL, Hyman BT. The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease. Neuron 2014; 82: 756–771.Sporns O, Honey CJ, Kötter R. Identification and classification of hubs in brain networks.  PLoS One. 2007 Oct 17;2(10):e1049.Stam CJ. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders. J. Neurol. Sci. 2010; 289: 128–134.Stam CJ. Modern network science of neurological disorders. Nat. Rev. Neurosci. 2014; 15: 683–695.Triggiani, A. I., Bevilacqua, V., Brunetti, A., Lizio, R., Tattoli, G., Cassano, F., … Babiloni, C. Classification of healthy subjects and Alzheimer’s disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks. Frontiers in Neuroscience. 2017; 10:604Tsvetanov KA, Henson RNA, Tyler LK, Davis SW, Shafto MA, Taylor JR, et al. The effect of ageing on fMRI: Correction for the confounding effects of vascular reactivity evaluated by joint fMRI and MEG in 335 adults. Hum. Brain Mapp. 2015; 36: 2248–2269.Uhlhaas PJ, Singer W. Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology. Neuron 2006; 52: 155–168.Whitwell JL, Josephs KA. Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep 2012; 12: 715–723.Williams, N., Henson, R., Taylor, J. & Cam-CAN. Measuring effective connectivity in resting-state MEG using PDC: effect of ageing in the Cam-CAN project. Poster presented at the Annual Scientific Meeting of the Organization for Human Brain Mapping (OHBM), Hamburg, Germany, 10 June 2014.Yu M, Engels MMA, Hillebrand A, van Straaten ECW, Gouw AA, Teunissen C, van der Flier WM, Scheltens P, Stam CJ. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.  Brain. 2017 May 1;140(5):1466-1485.Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain J. Neurol. 2010; 133: 1352–1367.Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome. Neuron. 2012; 73:1216-1227
Baillet S, Riera JJ, Marin G, Mangin JF, Aubert J, Garnero L. Evaluation of inverse methods and head models for EEG source localization using a human skull phantom. Phys. Med. Biol. 2001; 46: 77–96.
Bastos AM, Schoffelen J-M. A Tutorial Review of Functional Connectivity Analysis Methods and Their Interpretational Pitfalls. Front. Syst. Neurosci. 2016: 175.
Boeve BF. Links Between Frontotemporal Lobar Degeneration, Corticobasal Degeneration, Progressive Supranuclear Palsy, and Amyotrophic Lateral Sclerosis: Alzheimer Dis. Assoc. Disord. 2007; 21: S31–S38.
Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat. Rev. Neurosci. 2009; 10: 186–198.
Burrell JR, Hodges JR, Rowe JB. Cognition in corticobasal syndrome and progressive supranuclear palsy: A review. Mov. Disord. 2014; 29: 684–693.
Chan, D., Walters, R. J., Sampson, E. L., Schott, J. M., Smith, S. J., & Rossor, M. N.  EEG abnormalities in frontotemporal lobar degeneration. Neurology. 2004; 62: 9 1628-1630

Colclough GL, Woolrich MW, Tewarie PK, Brookes MJ, Quinn AJ, Smith SM. How reliable are MEG resting-state connectivity metrics? NeuroImage 2016; 138: 284–293.
Coyle-Gilchrist ITS, Dick KM, Patterson K, Rodríquez PV, Wehmann E, Wilcox A, et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 2016; 86: 1736–1743.
Cope TE, Rittman T, Borchert RJ, Jones PS, Vatansever D, Allinson K et al. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.Brain. 2018 Feb 1;141(2):550-567

Crossley NA, Mechelli A, Scott J, Carletti F, Fox PT, McGuire P, et al. The hubs of the human connectome are generally implicated in the anatomy of brain disorders. Brain 2014; 137: 2382–2395.
Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012; 11: 170–178.
Dauwels J, Vialatte F, Musha T, Cichocki A. A comparative study of synchrony measures for the early diagnosis of Alzheimer’s disease based on EEG. NeuroImage 2010; 49: 668–693.
van Dellen E, Hillebrand A, Douw L, Heimans JJ, Reijneveld JC, Stam CJ. Local polymorphic delta activity in cortical lesions causes global decreases in functional connectivity. NeuroImage 2013; 83: 524–532.
Fornito A, Zalesky A, Breakspear M. The connectomics of brain disorders. Nat. Rev. Neurosci. 2015; 16: 159–172.
Frank S, Clavaguera F, Tolnay M. Tauopathy models and human neuropathology: similarities and differences. Acta Neuropathol. (Berl.) 2007; 115: 39–53.
Ghosh BCP, Calder AJ, Peers PV, Lawrence AD, Acosta-Cabronero J, Pereira JM, et al. Social cognitive deficits and their neural correlates in progressive supranuclear palsy. Brain 2012; 135: 2089–2102.
Gonzalez-Moreno A, Aurtenetxe S, Lopez-Garcia M-E, del Pozo F, Maestu F, Nevado A. Signal-to-noise ratio of the MEG signal after preprocessing. J. Neurosci. Methods 2014; 222: 56–61.
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76: 1006–1014.
de Haan W, Mott K, van Straaten ECW, Scheltens P, Stam CJ. Activity Dependent Degeneration Explains Hub Vulnerability in Alzheimer’s Disease. PLoS Comput Biol 2012; 8: e1002582.
de Haan W, van der Flier WM, Koene T, Smits LL, Scheltens P, Stam CJ. Disrupted modular brain dynamics reflect cognitive dysfunction in Alzheimer's disease. Neuroimage. 2012 Feb 15;59(4):3085-93

de Haan W, Pijnenburg YAL, Strijers RLM, van der Made Y, van der Flier WM, Scheltens P, et al. Functional neural network analysis in frontotemporal dementia and Alzheimer’s disease using EEG and graph theory. BMC Neurosci. 2009; 10: 101.
Hayasaka S, Nichols TE. Combining voxel intensity and cluster extent with permutation test framework. NeuroImage 2004; 23: 54–63.
Hillman EMC. Coupling Mechanism and Significance of the BOLD Signal: A Status Report. Annu. Rev. Neurosci. 2014; 37: 161–181.
Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, et al.
Clinical Diagnosis of Progressive Supranuclear Palsy: The Movement Disorder Society Criteria  Mov. Disord. 2017; 32: 853–864.

Hu WT, McMillan C, Libon D, Leight S, Forman M, Lee VM-Y, et al. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 2010; 75: 595–602.
Huey ED, Putnam KT, Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology 2006; 66: 17–22.
Hughes LE, Ghosh BCP, Rowe JB. Reorganisation of brain networks in frontotemporal dementia and progressive supranuclear palsy. NeuroImage Clin. 2013; 2: 459–468.
Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. Improving response inhibition systems in frontotemporal dementia with citalopram. Brain 2015; 138: 1961–1975.
Hughes LE, Rowe JB. The Impact of Neurodegeneration on Network Connectivity: A Study of Change Detection in Frontotemporal Dementia. J. Cogn. Neurosci. 2013; 25: 802–813.
Jagust, W. Is amyloid- β harmful to the brain? Insights from human imaging studies. Brain. 2016; 139: 23–30

Knight RA, Verkhratsky A. Neurodegenerative diseases: failures in brain connectivity? Cell Death Differ. 2010; 17: 1069–1070.
Koss DJ, Robinson L, Drever BD, Plucińska K, Stoppelkamp S, Veselcic P, et al. Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology. Neurobiol. Dis. 2016; 91: 105–123.
Kurudenkandy FR, Zilberter M, Biverstål H, Presto J, Honcharenko D, Strömberg R, et al. Amyloid-β-Induced Action Potential Desynchronization and Degradation of Hippocampal Gamma Oscillations Is Prevented by Interference with Peptide Conformation Change and Aggregation. J. Neurosci. 2014; 34: 11416–11425.
Lakatos P, Karmos G, Mehta AD, Ulbert I, Schroeder CE. Entrainment of Neuronal Oscillations as a Mechanism of Attentional Selection. Science 2008; 320: 110–113.
Latora V, Marchiori M. Efficient behavior of small-world networks. Phys Rev Lett 2001;87:198701

Lindau, M., Jelic, V., Johansson, S.-E., Andersen, C., Wahlund, L.-O., & Almkvist, O.  Quantitative EEG abnormalities and cognitive dysfunctions in frontotemporal dementia and Alzheimer’s disease. Dementia and Geriatric Cognitive Disorders. 2003;15: 106–114

Lisman JE, Jensen O. The Theta-Gamma Neural Code. Neuron 2013; 77: 1002–1016.
Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996; 47: 1–9.
Long X, Zhang L, Liao W, Jiang C, Qiu B. Distinct laterality alterations distinguish mild cognitive impairment and Alzheimer’s disease from healthy aging: statistical parametric mapping with high resolution MRI. Hum Brain Mapp 2013;34:3400–10.

Maestu, F., Pena, J. M., Garces, P., Gonzalez, S., Bajo, R., Bagic, A.,  Magnetoencephalography International Consortium of Alzheimer’s, D. A multicenter study of the early detection of synaptic dysfunction in Mild Cognitive Impairment using Magnetoencephalography-derived functional connectivity. Neuroimage Clin. 2015; 9: 103-109

Medaglia, J. D., Huang, W., Segarra, S., Olm, C., Gee, J., Grossman, M., Bassett, D. S. (2017). Brain network efficiency is influenced by the pathologic source of corticobasal syndrome. Neurology, 2017; 89: 1373–1381 

Mandelli ML, Vilaplana E, Brown JA, Hubbard HI, Binney RJ, Attygalle S, et al. Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia. Brain 2016; 139: 2778–2791.
Meier J, Zhou X, Hillebrand A, Tewarie P, Stam CJ, Van Mieghem P. The epidemic spreading model and the direction of information flow in brain networks. Neuroimage. 2017 May 15;152:639-646.

Moon JY, Lee U, Blain-Moraes S, Mashour GA. General relationship of global topology, local dynamics, and directionality in large-scale brain networks.  PLoS Comput Biol. 2015 Apr 14;11(4):e1004225.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. J. Alzheimers Assoc. 2011; 7: 263–269.
Muthukumaraswamy SD. The use of magnetoencephalography in the study of psychopharmacology (pharmaco-MEG). J. Psychopharmacol. (Oxf.) 2014: 269881114536790.
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., Rabinovici, G. D. Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease. Brain. 2016; 139:1551–1567

Passamonti, L., Vazquez Rodriguez, P., Hong, Y. T., Allinson, K. S., Williamson, D., Borchert, R. J., … Rowe, J. B. 18F-AV-1451 positron emission tomography in Alzheimer’s disease and progressive supranuclear palsy. Brain. 2017; 140: 781–791
Palop JJ, Mucke L. Amyloid-β-induced neuronal dysfunction in Alzheimer’s disease: from synapses toward neural networks. Nat. Neurosci. 2010; 13: 812–818.
Pena-Ortega F, Solis-Cisneros A, Ordaz B, Balleza-Tapia H, Javier Lopez-Guerrero J. Amyloid Beta 1-42 Inhibits Entorhinal Cortex Activity in the Beta-Gamma Range: Role of GSK-3. Curr. Alzheimer Res. 2012; 9: 857–863.
Pereira, S., Hindriks, R., Miihlberg, S., Maris, E., van Ede, F., Griffa, A., Hagmann, P., Deco, G.   Effect of field spread on resting-state MEG functional network analysis: a computational modeling study. Brain Connectivity 2017; 7: 541-557 

Petersen, R. C., Doody, R., Kurz, a, Mohs, R. C., Morris, J. C., Rabins, P. V, Winblad, B. Current concepts in mild cognitive impairment. Archives of Neurology, 2001; 58: 1985–1992

Pievani, M., de Haan, W., Wu, T., Seeley, W. W., & Frisoni, G. B. Functional network disruption in the degenerative dementias. The Lancet Neurology. 2011:10: 829-843

Phillips HN, Blenkmann A, Hughes LE, Bekinschtein TA, Rowe JB. Hierarchical Organization of Frontotemporal Networks for the Prediction of Stimuli across Multiple Dimensions. J. Neurosci. 2015; 35: 9255–9264.
Poil, S. S., de Haan, W., van der Flier, W. M., Mansvelder, H. D., Scheltens, P., & Linkenkaer-Hansen, K. Integrative EEG biomarkers predict progression to Alzheimer’s disease at the MCI stage. Frontiers in Aging Neuroscience. 2013; 5:58

Poza J, Hornero R, Abasolo D, Fernandez A, Escudero J. Analysis of Spontaneous MEG Activity in Patients with Alzheimer’s Disease using Spectral Entropies. In: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2007. p. 6179–6182.
Quiroz, Y. T., Ally, B. A., Celone, K., McKeever, J., Ruiz-Rizzo, A. L., Lopera, F., … Budson, A. E. Event-Related potential markers of brain changes in preclinical familial Alzheimer disease. Neurology. 2011 77:469-75

Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, Pagliaro TA, et al. Distinct MRI Atrophy Patterns in Autopsy-Proven Alzheimer’s Disease and Frontotemporal Lobar Degeneration. Am. J. Alzheimers Dis. Other Demen. 2007; 22: 474–488.
Raj, A., Kuceyeski, A., & Weiner, M.. A Network Diffusion Model of Disease Progression in Dementia. Neuron. 2012; 73: 1204-1215

Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134: 2456–2477.
Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62: 42–52.
Selkoe DJ. Alzheimer’s Disease Is a Synaptic Failure. Science 2002; 298: 789–791.
Spires-Jones TL, Hyman BT. The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease. Neuron 2014; 82: 756–771.
Sporns O, Honey CJ, Kötter R. Identification and classification of hubs in brain networks.  PLoS One. 2007 Oct 17;2(10):e1049.

Stam CJ. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders. J. Neurol. Sci. 2010; 289: 128–134.
Stam CJ. Modern network science of neurological disorders. Nat. Rev. Neurosci. 2014; 15: 683–695.
Triggiani, A. I., Bevilacqua, V., Brunetti, A., Lizio, R., Tattoli, G., Cassano, F., … Babiloni, C. Classification of healthy subjects and Alzheimer’s disease patients with dementia from cortical sources of resting state EEG rhythms: A study using artificial neural networks. Frontiers in Neuroscience. 2017; 10:604

Tsvetanov KA, Henson RNA, Tyler LK, Davis SW, Shafto MA, Taylor JR, et al. The effect of ageing on fMRI: Correction for the confounding effects of vascular reactivity evaluated by joint fMRI and MEG in 335 adults. Hum. Brain Mapp. 2015; 36: 2248–2269.
Uhlhaas PJ, Singer W. Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology. Neuron 2006; 52: 155–168.
Whitwell JL, Josephs KA. Recent advances in the imaging of frontotemporal dementia. Curr Neurol Neurosci Rep 2012; 12: 715–723.
Williams, N., Henson, R., Taylor, J. & Cam-CAN. Measuring effective connectivity in resting-state MEG using PDC: effect of ageing in the Cam-CAN project. Poster presented at the Annual Scientific Meeting of the Organization for Human Brain Mapping (OHBM), Hamburg, Germany, 10 June 2014.

Yu M, Engels MMA, Hillebrand A, van Straaten ECW, Gouw AA, Teunissen C, van der Flier WM, Scheltens P, Stam CJ. Selective impairment of hippocampus and posterior hub areas in Alzheimer's disease: an MEG-based multiplex network study.  Brain. 2017 May 1;140(5):1466-1485.

Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain J. Neurol. 2010; 133: 1352–1367.
Zhou, J., Gennatas, E. D., Kramer, J. H., Miller, B. L., & Seeley, W. W.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome. Neuron. 2012; 73:1216-1227


Figure 1. Data analysis pipeline illustrating (i) preprocessing, to remove biological artefacts using MaxFilter and ICA denoising; (ii) Estimation of effective connectivity using multi-variate autoregressive modelling (MVAR); (iii) Compiling the association matrix between sensors by Partial Directed Coherence; (iv) Applying a statistical threshold to create a binarized graph, represented by the connectivity matrix; (v) Graph network analysis to estimate local efficiency; and (vi) group classification using a support vector machine (SVM). 

  
Figure 2. 3D scalp-frequency images of local efficiency. The schematic (top left) indicates the three projections: the topography (“Top”) for each frequency (1- 80Hz), an anterior-posterior (“AP”) projection, separating frequency but collapsing over left-right axis, and a “lateral” view, separating by frequency but collapsing over anterior-posterior axis. The five subplots indicate the T-value for the difference in local efficiency for each patient group versus controls (color bar on right). The cross-hair shows the peak T-statistic, while the black outline indicates regions surviving a cluster-corrected threshold of p<0.05.


Figure 3. Receiver operating characteristic (ROC) curves illustrate the performance of the Support Vector Machine classifier following principle component feature extraction for binary classifications between each pair of patient groups. The classification performance between patient groups is summarized by the area under the curve (AUC, inset). tAD = typical Alzheimer Disease; PCA = posterior cortical atrophy; bvFTD = behavioral variant frontotemporal dementia; navPPA= non-fluent variant primary progressive aphasia; PSP  = progressive supranuclear palsy.







